ArticleFrontiers in pharmacology2024

Adverse events related to neuromuscular blocking agents: a disproportionality analysis of the FDA adverse event reporting system.

Liangxia Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.